Anaemia during critical illness

British Journal of Anaesthesia

Volumn 97, Issue 3, 2006, Pages 278-291

  Walsh, T S ^a   Saleh, Ezz El Din ^a,b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Blood, erythrocytes; Blood, transfusion; Complications, anaemia; Intensive care

Indexed keywords

CYANOCOBALAMIN; ERYTHROPOIETIN; FERRITIN; FOLIC ACID; HEMOGLOBIN; IRON; PLACEBO; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ACUTE CORONARY SYNDROME; ANEMIA; BLEEDING; BLOOD SAMPLING; CELL MATURATION; CELL SURVIVAL; CLINICAL TRIAL; COMORBIDITY; CRITICAL ILLNESS; DISEASE SEVERITY; DRUG DOSE REGIMEN; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE TRANSFUSION; HEMATOCRIT; HEMODILUTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON METABOLISM; ISCHEMIC HEART DISEASE; OXYGEN DISSOCIATION CURVE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEPSIS; THROMBOCYTOPENIA;

EID: 33748081132     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/ael189     Document Type: Review

References (86)

1. Andrews NC. Anemia of inflammation: The cytokine-hepcidin link. J Clin Invest 2004; 113: 1251-3
2. Andrews T, Waterman H, Hillier V. Blood gas analysis: A study of blood loss in intensive care. J Adv Nurs 1999; 30: 851-7
3. Baskurt OK, Gelmont D, Meiselman HJ. Red blood cell deformability in sepsis. Am J Respir Crit Care Med 1998; 157: 421-7
4. Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost 2003; 29: 435-50
5. Beguin Y, Clemons GK, Pootrakul P, Fillet G. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 1993; 81: 1067-76
6. Bekyarova G, Yankova T, Kozarev I, Yankov D. Reduced erythrocyte deformability related to activated lipid peroxidation during the early postburn period. Burns 1996; 22: 291-4
7. Bellamy MC, Gedney JA. Unrecognised iron deficiency in critical illness. Lancet 1998; 352: 1903
8. Biesma DH, Van de Wiel A, Beguin Y, Kraaijenhagen RJ, Marx JJ. Post-operative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. Eur J Clin Invest 1995; 25: 383-9
9. -1 with survival. Anaesth Intensive Care 1991; 19: 581-3
10. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348: 1055-60
11. Chohan SS, McArdle F, McClelland DB, Mackenzie SJ, Walsh TS. Red cell transfusion practice following the transfusion requirements in critical care (TRICC) study: Prospective observational cohort study in a large UK intensive care unit. Vox Sang 2003; 84: 211-18
12. Claessens Y, Chiche J, Pene F, Dhainaut J, Mira J, Cariou A. Erythropoietin reverses septic shock-induced apoptosis of erythroid progenitors. Intensive Care Med 2003; S66
13. Cook D, Heyland D, Griffith L, Cook R, Marshall J, Pagliarello J. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. Crit Care Med 1999; 27: 2812-17
14. Cook DJ, Griffith LE, Walter SD, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001; 5: 368-75
15. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: Anemia and blood transfusion in the critically ill - current clinical practice in the United States. Crit Care Med 2004; 32: 39-52
16. Corwin HL, Gettinger A, Pearl RG, et al. Efficacy of recombinant human erythropoietin in critically ill patients: A randomized controlled trial. JAMA 2002; 288: 2827-35
17. Corwin HL, Gettinger A, Rodriguez RM, et al. Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial. Crit Care Med 1999; 27: 2346-50
18. Corwin HL, Krantz SB. Anemia of the critically ill: 'acute' anemia of chronic disease. Crit Care Med 2000; 28: 3098-9
19. Danielson B. R-HuEPO hyporesponsiveness - who and why? Nephrol Dial Transplant 1995; 10 (Suppl 2): 69-73
20. Eckardt KU. Anemia in critical illness. Wien Klin Wochenschr 2001; 113: 84-9
21. El Din S Ibrahim, McLellan SA, Walsh TS. Red blood cell 2,3-diphosphoglycerate concentration and in vivo P50 during early critical illness. Crit Care Med 2005; 33: 2247-52
22. Elliot JM, Virankabutra T, Jones S, et al. Erythropoietin mimics the acute phase response in critical illness. Crit Care 2003; 7: R35-40
23. Emmanuel JE, McClelland B, Page R, editors. The Clinical Use of Blood in Medicine, Obstetrics, Paediatrics, Surgery Anaesthesia, Trauma & Burns. World Health Organisation, 1997; 337.
24. French CJ, Bellomo R, Finfer SR, Lipman J, Chapman M, Boyce NW. Appropriateness of red blood cell transfusion in Australasian intensive care practice. Med J Aust 2002; 177: 548-51
25. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000; 96: 823-33
26. Hebert PC, Blajchman MA, Cook DJ, et al. Do blood transfusions improve outcomes related to mechanical ventilation.? Chest 2001; 119: 1850-7
27. Hebert PC, Fergusson D, Blajchman, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003; 289: 1941-9
28. Hebert PC, Fergusson DA. Do transfusions get to the heart of the matter? JAMA 2004; 292: 1610-12
29. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-17
30. Hebert PC, Wells G, Martin C, et al. Canadian survey of transfusion practices in critically ill patients. Transfusion Requirements in Critical Care Investigators and the Canadian Critical Care Trials Group. Crit Care Med 1998; 26: 482-7
31. Hebert PC, Wells G, Tweeddale, et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med 1997; 155: 1618-23
32. Hebert PC, Yetisir E, Martin C, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001; 29: 227-34
33. Hebert PC. The anemic patient in the intensive care unit: How much does the heart tolerate? Curr Opin Crit Care 2000; 6: 372-80
34. Henry ML, Garner WL, Fabri PJ. Iatrogenic anemia. Am J Surg 1986; 151: 362-3
35. Ho J, Sibbald WJ, Chin-Yee IH. Effects of storage on efficacy of red cell transfusion: When is it not safe? Crit Care Med 2003; 31: S687-97
36. Hobisch-Hagen P, Wiedermann F, Mayr A, et al. Blunted erythropoietic response to anemia in multiply traumatized patients. Crit Care Med 2001; 29: 743-7
37. Hogman CF, Knutson F, Loof H, Payrat JM. Improved maintenance of 2,3 DPG and ATP in RBCs stored in a modified additive solution. Transfusion 2002; 42: 824-9
38. Hutchinson C, Walsh TS, Black J, Ross JA. Soluble transferrin receptor assay as a marker of anaemia in critically ill patients. Br J Anaesth 2003; 90: 544P
39. Jelkmann W, Pagel H, Wolff M, Fandrey J. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 1992; 50: 301-8
40. Jongen-Lavrencic M, Peeters HR, Rozemuller H, et al. IL-6-induced anaemia in rats: Possible pathogenetic implications for anemia observed in chronic inflammations. Clin Exp Immunol 1996; 103: 328-34
41. Kayar E, Mat F, Meiselman HJ, Baskurt OK. Red blood cell rheological alterations in a rat model of ischemia-reperfusion injury. Biorheology 2001; 38: 405-14
42. Kirschenbaum LA, Astiz ME, Rackow EC, Saha DC, Lin R. Microvascular response in patients with cardiogenic shock. Crit Care Med 2000; 28: 1290-4
43. Krafte-Jacobs B, Levetown ML, Bray GL, Ruttimann UE, Pollack MM. Erythropoietin response to critical illness. Crit Care Med 1994; 22: 821-6
44. Lang KS, Duranton C, Poehlmann H, et al. Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ 2003; 10: 249-56
45. Leung JM, Weiskopf RB, Feiner J, et al. Electrocardiographic ST-segment changes during acute, severe isovolemic hemodilution in humans. Anesthesiology 2000; 93: 1004-10
46. MacLaren R, Sullivan PW. Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. Value Health 2005; 8: 105-16
47. Madjdpour C, Spahn DR. Allogeneic red blood cell transfusions: Efficacy, risks, alternatives and indications. Br J Anaesth 2005; 95: 33-42
48. McIntyre L, Hebert PC, Wells G, et al. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? J Trauma 2004; 57: 563-8
49. McLellan SA, McClelland DB, Walsh TS. Anaemia and red blood cell transfusion in the critically ill patient. Blood Rev 2003; 17: 195-208
50. McLellan SA, Walsh TS, McClellan DB. Should we demand fresh red blood cells for perioperative and critically ill patients? Br J Anaesth 2002; 89: 537-40
51. Morgan TJ, Koch D, Morris D, Clague A, Purdie DM. Reduced red cell 2,3-diphosphoglycerate concentrations in critical illness without decreased in vivo P50. Anaesth Intensive Care 2001; 29: 479-83
52. Nguyen BV, Bota DP, Melot C, Vincent JL. Time course of hemoglobin concentrations in nonbleeding intensive care unit patients. Crit Care Med 2003; 31: 406-10
53. O'Hare D, Chilvers RJ. Arterial blood sampling practices in intensive care units in England and Wales. Anaesthesia 2001; 56: 568-71
54. Patteril MV, Davey-Quinn AP, Gedney JA, Murdoch SD, Bellamy MC. Functional iron deficiency, infection and systemic inflammatory response syndrome in critical illness. Anaesth Intensive Care 2001; 29: 473-8
55. Piagnerelli M, Boudjeltia KZ, Brohee D, et al. Alterations of red blood cell shape and sialic acid membrane content in septic patients. Crit Care Med 2003; 31: 2156-62
56. Piagnerelli M, Boudjeltia KZ, Vanhaeverbeek M, Vincent JL. Red blood cell rheology in sepsis. Intensive Care Med 2003; 29: 1052-61
57. Pimentel M, Roberts DE, Bernstein CN, Hoppensack M, Duerksen DR. Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis. Am J Gastroenterol 2000; 95: 2801-6
58. Rao MP, Boralessa H, Morgan C, et al. Blood component use in critically ill patients. Anaesthesia 2002; 57: 530-4
59. Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292: 1555-62
60. Rasanen J. Supply-dependent oxygen consumption and mixed venous oxyhemoglobin saturation during isovolemic hemodilution in pigs. Chest 1992; 101: 1121-4
61. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-77
62. Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 2001; 16: 36-41
63. Rogiers P, Zhang H, Leeman M, et al. Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997; 23: 159-62
64. Scharte M, Fink MP. Red blood cell physiology in critical illness. Crit Care Med 2003; 31: S651-7
65. Shapiro MJ, Gettinger A, Corwin HL, et al. Anemia and blood transfusion in trauma patients admitted to the intensive care unit. J Trauma 2003; 55: 269-73
66. Shermock KM, Horn E, Lipsett PA, Pronovost PJ, Dorman T. Number needed to treat and cost of recombinant human erythropoietin to avoid one transfusion-related adverse event in critically ill patients. Crit Care Med 2005; 33: 497-503
67. Smoller BR, Kruskall MS, Horowitz GL. Reducing adult phlebotomy blood loss with the use of pediatric-sized blood collection tubes. Am J Clin Pathol 1989; 91: 701-3
68. Spahn DR, Casutt M. Eliminating blood transfusions: New aspects and perspectives. Anesthesiology 2000; 93: 242-55
69. Vamvakas EC. Meta-analysis of randomized controlled trials comparing the risk of postoperative infection between recipients of allogeneic and autologous blood transfusion. Vox Sang 2002; 83: 339-46
70. Vamvakas EC. WBC-containing allogeneic blood transfusion and mortality: a meta-analysis of randomized controlled trials. Transfusion 2003; 43: 963-73
71. van der Linden P, Schmartz D, De Groote F, et al. Critical haemoglobin concentration in anaesthetized dogs: Comparison of two plasma substitutes. Br J Anaesth 1998; 81: 556-62
72. van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, van de Wiel A. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000; 28: 2773-8
73. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499-507
74. von Ahsen N, Muller C, Serke S, Frei U, Eckardt KU. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 1999; 27: 2630-9
75. Walsh TS. Is stored blood good enough for critically ill patients?. Crit Care Med 2005; 33: 238-9
76. Walsh TS, Garrioch M, Maciver C, et al. Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion 2004; 44: 1405-11
77. Walsh TS, Lee RJ, Maciver C, et al. Anaemia during and at discharge from intensive care: The impact of restrictive blood transfusion practice. Intensive Care Med 2005; 32: 100-9
78. Walsh TS, McArdle F, McLellan SA, et al. Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients? Crit Care Med 2004; 32: 364-71
79. Walsh TS, McClelland DB. When should we transfuse critically ill and perioperative patients with known coronary artery disease? Br J Anaesth 2003; 90: 719-22
80. Walsh TS, McClelland DB, Lee RJ, et al. Prevalence of ischaemic heart disease at admission to intensive care and its influence on red cell transfusion thresholds: Multicentre Scottish Study. Br J Anaesth 2005; 94: 445-52
81. Walsh TS, Saleh E, Lee RJ, McClellan DBL. The prevalence and characteristics of anaemia at discharge home after intensive care. Intensive Care Med 2006; in press
82. Weiskopf RB, Kramer JH, Viele M, et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 2000; 92: 1646-52
83. Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998; 279: 217-21
84. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-23
85. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 345: 1230-6
86. Zaets SB, Berezina TL, Morgan C, et al. Effect of trauma-hemorrhagic shock on red blood cell deformability and shape. Shock 2003; 19: 268-73